Stock 000952 HUBEI GUANGJI PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hubei Guangji Pharmaceutical Co., Ltd.

Equities

000952

CNE0000010R5

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
5.9 CNY +2.97% Intraday chart for Hubei Guangji Pharmaceutical Co., Ltd. +7.27% -26.16%
Apr. 25 Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,502 2,370 2,565 2,694 2,711 2,828
Enterprise Value (EV) 1 2,925 2,786 2,559 2,778 2,944 3,349
P/E ratio 14.6 x 27.2 x 33.5 x 24.5 x 53.6 x -20.2 x
Yield - 0.73% 0.8% 0.77% - -
Capitalization / Revenue 2.96 x 3.24 x 3.73 x 3.22 x 3.4 x 3.83 x
EV / Revenue 3.47 x 3.81 x 3.72 x 3.32 x 3.69 x 4.54 x
EV / EBITDA 8.13 x 16 x 14.7 x 15.6 x 19.8 x 73.6 x
EV / FCF 25.3 x -61.3 x 49.7 x -43.3 x -21.3 x -6.29 x
FCF Yield 3.96% -1.63% 2.01% -2.31% -4.7% -15.9%
Price to Book 2.83 x 2.47 x 1.87 x 1.84 x 1.8 x 2.07 x
Nbr of stocks (in thousands) 302,047 298,452 343,401 344,000 353,974 353,974
Reference price 2 8.283 7.942 7.470 7.830 7.660 7.990
Announcement Date 3/15/19 4/23/20 3/23/21 3/24/22 4/19/23 4/25/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 843.8 731.3 688.2 837.1 797.6 737.8
EBITDA 1 359.9 174.4 174.2 178.1 148.5 45.53
EBIT 1 277.5 93.71 83.97 87.28 51.13 -73.22
Operating Margin 32.88% 12.81% 12.2% 10.43% 6.41% -9.92%
Earnings before Tax (EBT) 1 207.1 99.9 88.15 124.3 60.08 -140.7
Net income 1 171.7 86.94 74.65 110.1 50.37 -140.2
Net margin 20.35% 11.89% 10.85% 13.15% 6.31% -19.01%
EPS 2 0.5683 0.2917 0.2232 0.3201 0.1428 -0.3962
Free Cash Flow 1 115.8 -45.43 51.47 -64.23 -138.4 -532.3
FCF margin 13.72% -6.21% 7.48% -7.67% -17.35% -72.14%
FCF Conversion (EBITDA) 32.17% - 29.55% - - -
FCF Conversion (Net income) 67.42% - 68.94% - - -
Dividend per Share - 0.0583 0.0600 0.0600 - -
Announcement Date 3/15/19 4/23/20 3/23/21 3/24/22 4/19/23 4/25/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1
Net sales -
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 8.356
Net margin -
EPS 2 0.0237
Dividend per Share -
Announcement Date 4/28/22
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 423 416 - 84.9 232 521
Net Cash position 1 - - 6.43 - - -
Leverage (Debt/EBITDA) 1.175 x 2.387 x - 0.4769 x 1.563 x 11.44 x
Free Cash Flow 1 116 -45.4 51.5 -64.2 -138 -532
ROE (net income / shareholders' equity) 21.1% 9.02% 6.03% 7.51% 3.24% -10.6%
ROA (Net income/ Total Assets) 10.4% 3.39% 2.8% 2.71% 1.41% -1.66%
Assets 1 1,651 2,568 2,664 4,066 3,560 8,426
Book Value Per Share 2 2.930 3.220 3.990 4.250 4.250 3.850
Cash Flow per Share 2 0.5800 0.6200 1.020 0.8500 1.220 1.170
Capex 1 76.5 120 97.9 96.6 204 566
Capex / Sales 9.07% 16.38% 14.23% 11.54% 25.54% 76.73%
Announcement Date 3/15/19 4/23/20 3/23/21 3/24/22 4/19/23 4/25/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HUBEI GUANGJI PHARMACEUTICAL CO., LTD. Stock Hubei Guangji Pharmaceutical Co., Ltd.
-26.16% 288M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000952 Stock
  4. Financials Hubei Guangji Pharmaceutical Co., Ltd.